NCT05174598 - A Clinical Trial to Evaluate Efficacy and Safety of Two Different Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis | Biotech Hunter

Enrollment

278

Participants

Timeline

Start Date

October 3, 2018

Primary Completion Date

November 6, 2019

Study Completion Date

December 3, 2020

Conditions

Mild to Moderate Plaque Psoriasis

Interventions

DRUG

Calcipotriol/AKVANO, 50 μg/g cutaneous solution

Topical spray formulation containing Calcipotriol 50 μg/g. Twice daily treatment by spraying on a psoriasis affected area for 8 weeks.

DRUG

Calcipotriol Ointment 50 micrograms/g

Topical Ointment formulation containing Calcipotriol 50 micrograms/g. Twice daily treatment by applying on a psoriasis affected area for 8 weeks.

OTHER

Placebo

Topical spray formulation containing Vehicle of test formulation. Twice daily treatment by spraying on a psoriasis affected area for 8 weeks.

Trial Locations (14)

160012

Postgraduate Institute of Medical Education and Research, Chandigarh

221010

Surya Super Speciality Hospital, Varanasi

226006

Midland Healthcare & Research Center, Lucknow

382428

Kanoria Hospital & Research Centre, Gandhinagar

390021

GMERS Medical College & Hospital, Vadodara

391760

Dhiraj General Hospital, Vadodara

400001

Gokuldas Tejpal Hospital Grant Government Medical College & Sir JJ Group of Hospital, Mumbai

400706

Dr. D.Y. Patil Hospital, Mumbai

431001

Government Medical College, Aurangabad

492001

Sanjeevani CBCC USA Cancer Hospital, Raipur

524004

AC Subbareddy Government Hospital, Nellore

590010

KLES Dr. Prabhakar Kore Hospital & Medical Reserach Centre, Belagavi

781006

Downtown Hospital, Guwahati

781008

Marwari Hospital & Research Centre, Guwahati